Trial intelligence / Profile preview

Regulation of Endogenous Glucose Production by Central KATP Channels

NCT03540758Phase 2Recruiting

Sponsor
Albert Einstein College of Medicine
Start
Aug 2018
Primary completion
Apr 2027
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of diazoxide in diabetes mellitus (DM), glucose metabolism disorders, sponsored by Albert Einstein College of Medicine. Started Aug 2018; status: recruiting.

02

Drugs

diazoxide
03

Conditions

diabetes mellitus (DM)glucose metabolism disorders

Beyond the preview

Go deeper on NCT03540758.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03540758.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call